DrugPatentWatch Database Preview
Becaplermin - Biologic Drug Details
» See Plans and Pricing
Summary for becaplermin
| Tradenames: | 1 |
| Patents: | 23 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for becaplermin |
Recent Clinical Trials for becaplermin
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Adocia | Phase 1/Phase 2 |
| Virchow Group | Phase 1/Phase 2 |
| Bedford Research Corporation, Inc. | N/A |
Pharmacology for becaplermin
| Ingredient-type | Platelet-Derived Growth Factor |
Company Disclosures: US Patents for becaplermin
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | Ethicon, Inc. (Somerville, NJ) | 2012-10-10 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for becaplermin
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | LTS Lohamann Therapie-Systeme AG (Andernach, DE) | 2019-06-04 | RX | search | |
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | University of Louisville Research Foundation, Inc. (Louisville, KY) | 2022-05-14 | RX | search | |
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | University of Louisville Research Foundation, Inc. (Louisville, KY) | 2022-05-14 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for becaplermin
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 9712601 | Start Trial |
| Japan | 2014217769 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2013120497 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for becaplermin
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0034 | Belgium | Start Trial | PRODUCT NAME: BECAPLERMIN; REGISTRATION NO/DATE: EU/1/99/101/001 19990329 |
| C/GB99/023 | United Kingdom | Start Trial | PRODUCT NAME: BECAPLERMIN; REGISTERED: UK EU/1/99/101/001 19990329 |
| 36/1999 | Austria | Start Trial | PRODUCT NAME: BECAPLERMIN |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
